Inogen (INGN) Reports In-Line Q4 EPS

Inogen (NASDAQ: INGN) reported Q4 EPS of $0.11, in-line with the analyst estimate of $0.11. Revenue for the quarter came in at $50.9 million versus the consensus estimate of $46.52 million.

GUIDANCE:

Inogen sees FY2017 revenue of $233-239 million, versus the consensus of $234.5 million.

For earnings history and earnings-related data on Inogen (INGN) click here.

You May Also Be Interested In

• Wolfe Research starts Ferrari at Outperform, sees 'solid upside potential'
• Tradeweb Markets (TW) PT Lowered to $151 at Raymond James
• Syra Health names Dr. Cori McMahon as fractional chief medical officer